Recruiting

Biomarkers in Pneumonia

Sponsor:

NIH

Code:

NCT00077909

Conditions

Pneumonia

Pulmonary Disease

Lung Disease

Eligibility Criteria

Sex: All

Age: 3 - 70+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study will examine the different types of proteins present in the lungs of patients with pneumonia to explore the causes of different types of the disease. Pneumonia is a condition that causes lung inflammation AND is often caused by an infection. It is usually diagnosed by lung x-rays and listening to the chest with a stethoscope. This method can diagnose pneumonia, but it does not provide information on the cause of the inflammation - information that might be helpful in guiding treatment. This study will measure proteins in the lungs of patients to see if certain proteins are associated with specific forms of pneumonia, and can thus serve as biomarkers for disease.

Patients undergoing diagnostic bronchoscopy at the NIH Clinical Center may participate in this study. Patients will undergo bronchoscopy and bronchoalveolar lavage as scheduled for their medical care. For this procedure, the patient's mouth and throat are numbed with lidocaine; a sedative may be given for comfort. A thin flexible tube called a bronchoscope is advanced through the nose or mouth into the lung airways to examine the airways carefully. Saline (salt water) is then injected through the bronchoscope into the air passage, acting as a rinse. A sample of fluid is then withdrawn for microscopic examination. Researchers in the current study will use some of the fluid obtained from the lavage to examine for protein content.

In addition to the bronchoscopy and bronchoalveolar lavage, participants will have about 2 tablespoons of blood drawn to compare blood test results with the results of the lung washings. Patients' medical records will be reviewed to obtain information on past medical history, current medical treatment, vital signs, and results of x-ray tests.

Conditions

Pneumonia

Pulmonary Disease

Lung Disease

Study ID

NCT00077909

Start date

Feb 20, 2004

Status verified date

Apr 9, 2026

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 3 - 70+

Healthy Volunteers: Not accepted

  • INCLUSION CRITERIA:
  • All eligible patients undergoing diagnostic bronchoscopy who provide consent for proteomic analysis of BAL fluid supernatant and chart review of patient characteristics will be included in this study.
  • A parent/guardian may provide consent for a child age 17 or under and a Legally Authorized Representative (LAR) may provide consent for adults unable to consent.

EXCLUSION CRITERIA:

Patients undergoing bronchoscopy but not wanting to participate with either the chart review or the proteomic analysis of BAL fluid supernatant will be excluded.

Study Design

Enrollment

750 participants

Anticipated

Interventions and Outcome Measures

Arms

Group 1

Patients with Infectious Pneumonia

Group 2

Patients with Non-Infectious Pneumonia

Primary outcome measure

  • Peptide biomarker [ Time Frame: Batch-driven analysis of samples. ]
  • Characterization of lung cells associated with pneumonia [ Time Frame: Batch-driven analysis of samples. ]

Central Contacts and Locations

Central contacts

Gloria Y Pastor, C.R.N.P.

(301) 402-3484pastorg@cc.nih.gov

Anthony F Suffredini, M.D.

(301) 496-9320asuffredini@mail.nih.gov

Locations

National Institutes of Health Clinical Center

Recruiting

Bethesda, Maryland, United States, 20892

More Information

Sponsor

National Institutes of Health Clinical Center (CC)

Last update posted

Aug 28, 2026

Last verified

Apr 9, 2026

Keywords

  • Proteomics
  • Infection
  • Pneumonia
  • Mass Spectrometry
  • BAL
  • Natural History
  • Lung
  • Pulmonary Disease
  • Lung Infiltrates

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Institutes of Health Clinical Center (CC) on 2026-08-28.